Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling

Pre-metabolic syndrome (pre-MetS) may represent the best transition phase to start treatments aimed at reducing cardiometabolic risk factors of MetS. In this study, we investigated the effects of the marine microalga Tisochrysis lutea F&M-M36 (T. lutea) on cardiometabolic components of pre-MetS...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Ambrosio, Mario, Bigagli, Elisabetta, Cinci, Lorenzo, Gencarelli, Manuela, Chioccioli, Sofia, Biondi, Natascia, Rodolfi, Liliana, Niccolai, Alberto, Zambelli, Francesca, Laurino, Annunziatina, Raimondi, Laura, Tredici, Mario R., Luceri, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222845/
https://www.ncbi.nlm.nih.gov/pubmed/37233497
http://dx.doi.org/10.3390/md21050303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222845/
https://www.ncbi.nlm.nih.gov/pubmed/37233497
http://dx.doi.org/10.3390/md21050303

Ejemplares similares